21
Nov
2024
Speaking Up for Science and Health. Even When Inconvenient
“By their fruits, ye shall know them” –Matthew 7:16 Immediately following the election of Donald Trump, a number of publications asked leaders of the biopharmaceutical industry and investment community to share their thoughts on how his likely policies and appointees to key positions of leadership will affect our industry. Many of these leaders counseled us to “wait and see” before making... Read More
22
Apr
2017
Steve Holtzman on Why Biotech Should Stand Up for Science
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.